| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Estonian Biocentre, Riia 23, 51010, Tartu, Estonia
2 Institute of Technology, University of Tartu, Nooruse 1, 50411, Tartu, Estonia
Correspondence
Andres Merits
andres.merits{at}ut.ee
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). The early replicase complex mediates synthesis of a negative-strand RNA complementary to the genomic RNA. Subsequently, minus strands are used by the late replicase complex as templates for new genomic and subgenomic RNAs (sgRNAs). The latter are used for the translation of structural proteins. In the replicon vector system, the coding region of structural genes is replaced with a polylinker and/or foreign gene sequences. The replicon RNA is self-replicating and can be packaged into virus-like particles (VLPs) if the genes encoding the structural proteins are provided by additional helper RNA (Liljestrom & Garoff, 1991).
nsP2 is an essential and multifunctional component of the viral replicase complex. Its N-terminal domain has NTPase, RNA triphosphatase and RNA helicase activities (Gomez de Cedron et al., 1999; Rikkonen et al., 1994a; Vasiljeva et al., 2000). The C-terminal domain of nsP2 is responsible for the processing of non-structural polyprotein (Strauss & Strauss, 1994). nsP2 has also been reported to be essential for the cessation of negative-strand RNA synthesis in the late stage of the infection cycle and for the regulation of sgRNA synthesis, possibly through stabilization of the late replicase complex. Mutations in nsP2 result in unstable late replicase complexes, a severe reduction in viral RNA synthesis and in continuous minus-strand synthesis in infected BHK-21 cells (Sawicki et al., 2006).
In susceptible vertebrate cells, alphavirus infection strongly affects cellular metabolism, causing inhibition of transcription and translation, and cell death. Alphavirus-induced shutdown of host-cell transcription and translation involves separate processes (Gorchakov et al., 2005), and nsP2 plays a major role in these processes for Old World alphavirus infections (Garmashova et al., 2007). Mutations in the C terminus of nsP2 of SFV or Sindbis virus (SIN) are often responsible for persistent infection or prolonged survival of infected cells (Dryga et al., 1997; Frolov et al., 1999; Perri et al., 2000), and have been used to construct alphavirus-based replicons with reduced cytotoxicity (Agapov et al., 1998; Lundstrom et al., 2001, 2003).
In SFV-infected cells, approximately half of the nsP2 is transported to the nucleus (Peranen et al., 1990; Rikkonen, 1996). The nuclear localization of nsP2 has been proposed as a trigger for transcriptional shutdown and apoptosis of infected cells (Rikkonen et al., 1994b). The pentapeptide 648PRRRV652 has been identified as the nuclear localization signal (NLS) of nsP2. Replacement of arginine 649 with aspartic acid changed the localization of nsP2 to entirely cytoplasmic (Rikkonen et al., 1992). SFV harbouring the corresponding mutation was viable (Rikkonen et al., 1994b) and showed attenuated neuropathogenicity, resulting in slower viral spread and reduced cell death in infected adult mice brain neurons (Fazakerley et al., 2002). However, this alteration in NLS did not prevent apoptosis in infected BHK-21 cells.
In the present study, we compared different NLS mutants of nsP2 to determine the residues critical for SFV RNA synthesis, gene expression and virus-induced cytotoxicity, and investigated possible underlying mechanisms. The non-cytotoxic phenotype correlated with reduced accumulation of SFV RNA. All SFV mutants that retained the cytotoxic phenotype also retained some transport of nsP2 into the nucleus, but not necessarily vice versa. Thus, it is hypothesized that at least two events – nuclear localization of nsP2 and a sufficiently high accumulation of viral RNA – are necessary for cytotoxicity.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Construction of SFV mutant replicons, genomes and helper constructs.
All recombinant viruses, replicons and helper RNAs were based on the previously described plasmids pSP6-SFV4 (Liljestrom et al., 1991), pSFV1, pHelper1 (Liljestrom & Garoff, 1991) and pHelperC (Smerdou & Liljestrom, 1999). Mutations designated DDD, RDD, DDR, RDR, RRD, 
, R and RR were introduced into the NLS of nsP2 (648RRR650) by PCR-based mutagenesis. Mutated DNA fragments were introduced by subcloning into pSFV1-d1EGFP (Zusinaite et al., 2007) and the resulting replicon plasmids were designated pSFV1-d1EGFP-DDD, pSFV1-d1EGFP-RDD, pSFV1-d1EGFP-DDR, pSFV1-d1EGFP-RDR, pSFV1-d1EGFP-RRD, pSFV1-d1EGFP-, pSFV1-d1EGFP-R and pSFV1-d1EGFP-RR. The replacement of proline for glycine at the position 718 of nsP2 was performed similarly and the corresponding replicon plasmid was designated pSFV1-d1EGFP-PG. For some assays, the polylinker–d1EGFP region of these plasmids was replaced by an expanded multiple cloning site (MCS), by the firefly luciferase sequence (Luc), by the SFV capsid enhancer and the foot-and-mouth disease virus 2A autoprotease and the luciferase sequence (EnhLuc) or by the puromycin N-acetyltransferase sequence (Pac); corresponding replicon plasmids were designated pSFV1-MCS, pSFV1-Luc, pSFV1-EnhLuc and pSFV1-Pac, respectively.
Plasmids containing full-length infectious cDNA of SFV4-RDD, SFV4-DDR, SFV4-RDR, SFV4-RRD, SFV4-R, SFV4-RR and SFV4-PG were created by replacement of the BglII–SpeI fragment in the corresponding replicon plasmids originating from pSFV1-d1EGFP by the BglII–SpeI fragment from pHelper1.
To construct helper RNAs expressing marker proteins, the coding sequence of the structural proteins from pHelper1 was replaced by a polylinker. The sequences encoding Luc or EnhLuc were transferred to this polylinker from pSFV1-Luc and pSFV1-EnhLuc, respectively. The resulting plasmids were designated pH-SG-Luc and pH-SG-EnhLuc. Sequences of all primers and constructed plasmids are available upon request.
RNA transcription and transfection.
SFV-based replicon plasmids, helper plasmids and infectious cDNA plasmids were linearized by SpeI digestion. The RNAs were synthesized in vitro using SP6 RNA polymerase and used for cell transfection by electroporation as described by Karlsson & Liljestrom (2003); transfection efficiency was >95 % in all experiments. For VLP production, BHK-21 cells were co-transfected with equal amounts of in vitro-transcribed Helper1 RNA and replicon RNAs.
Collection of virus stocks and VLPs.
Primary virus stocks or VLPs were collected from transfected BHK-21 cell cultures after incubation at 28 °C for 72 h. Virus titres were determined by plaque assay. VLP titres were determined by infecting BHK-21 cells with different dilutions of VLP stocks in serum-free media and counting d1EGFP-positive cells at 48 h post-infection (p.i.).
Immunofluorescence microscopy.
BHK-21 cells were grown on cover slips and infected with virions in serum-free medium at an m.o.i. of 1; mock-infected cells were used as controls. At 8 or 24 h p.i., cells were washed with PBS, fixed with 4 % paraformaldehyde for 10 min at room temperature and permeabilized with cold methanol for 6 min at –20 °C. Cells were washed with PBS, blocked in 5 % FCS in PBS and incubated for 1 h with rabbit polyclonal antibody against SFV nsP2. Alexa Fluor 488 (Invitrogen)-labelled anti-rabbit antibody was used as a secondary antibody. Samples were analysed on a Nikon D-Eclipse C1 confocal microscope.
Analysis of cytotoxicity of SFV vectors.
The cytotoxicity of SFV vectors was analysed essentially as described by Garmashova et al. (2006). Five micrograms of in vitro-synthesized RNA from pSFV1-Pac-type vectors was electroporated into 106 BHK-21 cells; mock-transfected cells were used as controls. The cells were seeded into 24-well culture plates (growth area 2.0 cm2 per well) and puromycin selection (10 µg ml–1) was applied from 16 h post-transfection (p.t.). Numbers of viable adherent cells were determined at 2, 24, 48, 93, 141, 237 and 312 h p.t. using trypan blue (Flow Laboratories) exclusion.
Metabolic labelling.
BHK-21 cells were transfected with 50 µg in vitro-synthesized RNA or infected with virus particles at an m.o.i. of 1. For each transfection, 5x106 cells were used. Depending on the experiment, transfected cells were seeded into four or six 35 mm diameter plates. For infection, 2x105 cells on 35 mm plates were used for each time point. At selected times, transfected or infected cells were washed twice with PBS and once with methionine- and cysteine-free Dulbecco's modified Eagle's medium, followed by incubation for 1 h in the latter medium. The cells were then labelled with 50 µCi [35S]methionine and [35S]cysteine (RedivuePRO-MIX; Amersham Biosciences) ml–1 for 1 h. After labelling, the cells were washed with PBS, lysed in 50 µl Laemmli buffer and subjected to 12 % SDS-PAGE; 5 µl lysate was loaded into each well.
Pulse–chase experiments and immunoprecipitation.
Polyprotein processing was studied by pulse-labelling of the cells with [35S]methionine. BHK-21 cells (106) were infected at an m.o.i of 5 and labelled at 6 h p.i. for 0.5 h. In chase samples, the pulse was followed by a chase for 1 h in the presence of excess of unlabelled methionine. Cells were then lysed in 1 % SDS and the proteins denatured by boiling. Samples were diluted 1 : 20 with NET buffer [50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.5 % NP-40] and incubated for 1 h at 4 °C with rabbit polyclonal antiserum against non-structural proteins (Salonen et al., 2003). Immunocomplexes were precipitated with Protein A–Sepharose CL-4B (Amersham Biosciences) overnight at 4 °C. The precipitates were washed four times with NET buffer containing 400 mM NaCl. The precipitated proteins were denatured by heating in Laemmli buffer and the samples were separated by SDS-PAGE. The labelled proteins were detected by autoradiography.
Quantification of luciferase expression and Western blotting.
For in cis expression assays, 2x105 BHK-21 cells were transfected with 2 µg SFV1-Luc-type or SFV1-EnhLuc-type RNA; for in trans expression assays, combinations of SFV1-MCS-type RNA with H-SG-Luc or H-SG-EnhLuc RNA (2 µg each) were used. Electroporated cells were seeded into two wells (growth area 2.0 cm2 per well) and incubated for 24 h at 28 °C. Cells from one well were lysed and analysed using the Luciferase Assay System (Promega) on a Turner Designs luminometer. Cells from another well were lysed using Laemmli buffer and the expressed proteins were subjected to 12 % SDS-PAGE. Proteins were transferred to a nitrocellulose membrane and probed either with rabbit polyclonal antisera against SFV nsP1 or with a mouse monoclonal antibody against β-actin (Abcam). Western blots were visualized using an ECL Immunoblot Detection kit (Amersham Life Science).
Northern blot analysis.
BHK-21 cells (5x106) were co-transfected with 6 µg SFV1-MCS-type RNA and 6 µg H-SG-EnhLuc RNA. Transfected cells were divided among three plates and incubated at 28 °C for 24, 48 or 72 h. Total RNA from transfected cells was purified with TRIzol reagent (Invitrogen). Equal amounts of total RNA were denatured for 10 min at 65 °C in formamide/formaldehyde buffer and separated by electrophoresis in 1.5 % agarose gel supplemented with 0.2 M formaldehyde. The separated RNAs were transferred to Hybond-N+ membrane (Amersham Biosciences) and UV cross-linked. Hybridization was performed using a standard procedure. The bound radioactivity was quantified using Typhoon TRIO equipment and ImageQuant TL software (Amersham Biosciences).
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
; Rikkonen et al., 1992). In order to screen the NLS sequence of nsP2 for changes with potential impact on SFV cytotoxicity, we constructed and analysed six novel mutant replicons and viruses carrying substitutions/deletions in the 648RRR650 sequence of nsP2. These included substitution of two or three arginines with aspartic acids (DDD, RDD and DDR), or complete or partial deletion of the 648RRR650 sequence (, R and RR). Two previously described mutants (RDR and RRD; Rikkonen, 1996; Rikkonen et al., 1992) were also included in the study. In addition, an nsP2 mutant with a 718P
G substitution was constructed. The latter is a counterpart of the SIN/G mutant harbouring a 726PG mutation, allowing persistent non-cytopathic replication of SIN RNA replicons and genomes in BHK-21 cells (Frolov et al., 1999; Gorchakov et al., 2004).
To test the effect of these mutations on SFV viability, the corresponding replicons expressing the d1EGFP marker were transfected into BHK-21 cells. d1EGFP expression at 37 °C occurred only in cells transfected with replicons harbouring PG, RDR and RRD mutations. Replicons with R, RR, RDD and DDR mutations showed a temperature-sensitive phenotype; almost 100 % of transfected cells were d1EGFP-positive for all of these constructs at the permissive temperature (28 °C) (data not shown). In order to include these replicons and corresponding viruses in the analysis, subsequent assays were carried out at 28 °C. In contrast to mutants described above, at most a few cells expressed d1EGFP following transfection with SFV1-d1EGFP-DDD, and no d1EGFP expression was detected following transfection with SFV1-d1EGFP- (data not shown).
Subcellular localization of nsP2 expressed by mutant SFV genomes
Subcellular localization of nsP2 in cells infected with SFV4, SFV4-R, SFV4-RR, SFV4-DDR, SFV4-RDD, SFV4-PG, SFV4-RRD or SFV4-RDR was detected at 8 and 24 h p.i. nsP2 was found exclusively in the cytoplasm of SFV4-RDD-infected cells both 8 and 24 h p.i. (Fig. 1a, b). Localization of nsP2 in SFV4-DDR- and SFV4-R-infected cells was exclusively cytoplasmic at 8 h p.i. (Fig. 1a) and mostly cytoplasmic at 24 h p.i. (Fig. 1b), whereas in SFV4-RDR-infected cells there was some nuclear localization of nsP2 at both times p.i. In SFV4-RR- and SFV4-PG-infected cells, nsP2 was almost entirely nuclear (Fig. 1a, b). The localization of nsP2 in cells infected with SFV4-RRD resembled SFV4-infected cells and changed from mainly nuclear during early infection to predominantly cytoplasmic later (Fig. 1a, b).
|
; Salonen et al., 2003), whereas introduction of the RDR mutation into nsP2 results in slower non-structural-polyprotein processing (Fazakerley et al., 2002; Rikkonen, 1996). To determine the effect of the NLS mutations on non-structural polyprotein processing, pulse–chase labelling followed by immunoprecipitation was carried out. The only difference compared with SFV4 was a small delay in P12 and P34 processing observed for SFV4-DDR and SFV4-R at 8 h p.i. (Fig. 2). Thus, the detected slow-down of processing may have contributed to the change of nsP2 localization observed for these viruses from strictly cytoplasmic to partially nuclear (Fig. 1a, b
).
|
; Rikkonen, 1996). Based on this assumption, NLS mutations that prevent nsP2 movement to the nucleus of infected cells should also reduce SFV cytopathogenicity.
SFV1-Pac-type replicons were used to analyse the cytotoxic effect of SFV replicons with mutations in nsP2. Puromycin selection was applied from 16 h p.t. to ensure that transfected cells had established a puromycin-resistant phenotype. The percentage of viable adherent cells was determined at 24, 48, 93, 141, 237 and 312 h p.t. (Fig. 3). Based on the data obtained, the mutant SFV replicons were divided into two groups. The first group was SFV1-Pac, SFV1-Pac-RRD, SFV1-Pac-RDR and SFV-Pac-RR, with highly cytotoxic replication. SFV1-Pac-RDD, SFV1-Pac-PG, SFV1-Pac-DDR and SFV1-Pac-R formed the second group and had significantly diminished cytotoxicity. The number of viable cells in this group was stable or slightly increased (SFV1-Pac-RDD and SFV1-Pac-PG), or decreased slowly (SFV1-Pac-DDR and SFV1-Pac-R) (Fig. 3).
|
). Metabolic labelling was used to study the effects of recombinant SFV replicons on host-cell-specific protein synthesis. BHK-21 cells were co-transfected with in vitro-synthesized RNAs of replicons expressing d1EGFP and HelperC RNA, and pulse-labelled at 4, 12, 24, 36, 48 and 72 h p.t. HelperC was used to gain information about translational efficiency from the subgenomic promoter located in trans. As expected, protein synthesis in cells transfected with SFV1-d1EGFP was rapidly inhibited in contrast to mock-infected cells (Fig. 4). Only slightly slower shutdown of host protein synthesis was detected in cells transfected with SFV1-d1EGFP-RR, SFV1-d1EGFP-RDR (Fig. 4), SFV1-d1EGFP-DDR and SFV1-d1EGFP-R transcripts (data not shown). In contrast, no decrease in host-cell translation was detected in SFV1-d1EGFP-RDD- and SFV1-d1EGFP-PG-transfected cells (Fig. 4).
|
; Singh & Helenius, 1992; Wengler et al., 2003). Therefore, the shutdown of host-cell translation was also analysed for cells transfected with transcripts from infectious cDNA clones containing mutations in the nsP2 region. The results of this experiment were very similar to those for the corresponding replicon vectors. Transfection of cells with SFV4 RNA caused rapid shutdown of host-cell protein synthesis, whilst transfection with SFV4-RDD or SFV4-PG RNA did not (Fig. 5a). Thus, the presence and expression of structural genes did not induce shutdown of host-cell translation. In contrast, in cells infected with SFV4-RDD or SFV4-PG virions, shutdown of cellular translation was similar to that in SFV4-infected cells (Fig. 5b). RT-PCR and sequencing were used to confirm the presence of the RDD and PG mutations, showing that the phenotypic change could not be attributed to reversion.
|
Packing efficiency of mutant replicons correlates with the level of sgRNA-mediated protein expression
The ability of non-cytotoxic-alphavirus-based replicons to be packaged into VLPs by supplementing with helper RNAs for structural proteins can be significantly reduced (Perri et al., 2000). In the present study, most replicons with mutations in the NLS of nsP2 were packaged into VLPs as efficiently as the parental SFV1-d1EGFP: typically approximately 250 VLPs were obtained per SFV1-d1EGFP-transfected cell, whilst the yield ranged from 200 to 270 VLPs per transfected cell for SFV1-d1EGFP-RRD, SFV1-d1EGFP-RDR, SFV1-d1EGFP-DDR, SFV1-d1EGFP-RR and SFV1-d1EGFP-R. The exceptions were SFV1-d1EGFP-RDD and SFV1-d1EGFP-PG, which generally produced less than one VLP per transfected cell. As neither mutation overlapped the SFV packaging signal (White et al., 1998), we analysed mutant replicons for defects in structural protein expression and/or replicon RNA production.
Metabolic labelling (Fig. 4) showed different expression levels of in trans-encoded capsid protein and in cis-encoded d1EGFP, translated from sgRNAs. Capsid protein was expressed most efficiently (albeit briefly) in cells where HelperC RNA was co-transfected with SFV1-d1EGFP RNA. In the same cells, the expression of d1EGFP marker, which unlike capsid protein did not have the translational enhancer, was the lowest and the shortest (Fig. 4). In cells co-transfected with SFV1-d1EGFP-RDR or SFV1-d1EGFP-RR, capsid protein expression lasted until 72 h p.t., and in cells co-transfected with SFV1-d1EGFP-RDD or SFV1-d1EGFP-PG, capsid protein continued to be expressed at low levels up to 72 h p.i. The expression profile of d1EGFP protein was very similar to that of capsid protein in all these cells (Fig. 4). Thus, the expression of marker proteins depended on the presence or absence of the capsid enhancer sequence and the ability of the replicon to shut down cellular translation. The cis/trans localization of the marker gene may have affected translational efficiency.
Expression from sgRNAs was evaluated in detail using a reporter system with a luciferase marker expressed from a subgenomic promoter, located either on the replicon RNA (in cis) or on the separate helper RNA H-SG-Luc (in trans). The impact of the capsid enhancer sequence on the expression of marker proteins was also studied. Western blot analysis of transfected cells revealed that all mutant replicons produced roughly equal amounts of non-structural proteins (Fig. 6d). Similarly, in the absence of translational enhancer, expression levels of the luciferase marker from in cis subgenomic promoters by mutant replicons were similar to or higher than those of SFV1-Luc (Fig. 6b). However, from the in trans subgenomic promoter, the levels of luciferase activity with mutant replicon transfections were reduced compared with SFV1-MCS. The reduction was greatest for the SFV1-MCS-RDD and SFV1-MCS-PG replicons (Fig. 6c). The addition of a translational enhancer increased luciferase expression approximately 10-fold in the case of transfection with wild-type replicons, in agreement with Sjoberg et al. (1994). In contrast, the enhancer had no effect for most mutant replicons and was negative for SFV1-EnhLuc-RDD and SFV1-EnhLuc-PG (Fig. 6b, c). Thus, one reason for low efficiency of VLP formation of RDD and PG mutants could be significantly decreased protein expression from the subgenomic promoter on the Helper1 RNA.
|
; Dryga et al., 1997; Frolov et al., 1999; Perri et al., 2000; Sawicki et al., 2006). In the present study, we determined levels of positive-strand (genomic and subgenomic) RNA synthesis in BHK-21 cells co-transfected with either SFV1-MCS-RDD and H-SG-EnhLuc or SFV1-MCS-PG and H-SG-EnhLuc transcripts using Northern blotting. Transcripts of SFV1-MCS, SFV1-MCS-RRD and SFV1-MCS-RR were included as controls.
The replication of replicon RNAs and transcription from the subgenomic promoter were strongly impaired for SFV1-MCS-RDD and SFV1-MCS-PG (Fig. 7b). For both SFV1-MCS-PG and SFV1-MCS-RDD, the amount of replicon RNA was at least 30-fold lower than for SFV1-MCS. The amount of sgRNA synthesized by SFV1-MCS-RDD and SFV1-MCS-PG was reduced to a lesser extent as there was a 3–6-fold reduction at different times. The molar ratio of sgRNAs and genomic RNA was also changed (Fig. 7b), from typically 15 : 1 for SFV1-MCS, SFV1-MCS-RRD and SFV1-MCS-RR to at least 100 : 1 for SFV1-MCS-RDD and SFV1-MCS-PG. Thus, the RDD and PG mutations in nsP2 affected genomic RNA synthesis more severely than that of sgRNA.
|
). Compared with SFV1-MCS, there was an approximately 4–6-fold reduction in synthesis of both genomic and sgRNA for H-SG-EnhLuc co-transfected with SFV1-MCS-RRD or SFV1-MCS-RR. RDD and PG substitutions in nsP2 severely inhibited the synthesis of genomic and sgRNAs from H-SG-EnhLuc; the corresponding products could not be detected (Fig. 7c). Thus, sgRNA expression correlated well with marker protein expression. In the case of SFV1-Luc-PG and SFV1-Luc-RDD, the reduction in sgRNA synthesis is compensated by the lack of translational shutdown. In contrast, the structural protein expression from the helper RNAs is severely downregulated due to suppression of synthesis of the corresponding sgRNAs and the lack of translational shutdown needed to activate the capsid enhancer element. |
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
), shutting down cellular transcription and translation and inducing cell death. The mechanisms and pathways of these effects are poorly understood, but events in the nucleus of the infected cell may be important. The partial transport of nsP2 into the nucleus of SFV-infected cells could trigger the mechanisms determining the cytopathogenicity of SFV infection (Peranen et al., 1990; Rikkonen, 1996). In the present study, we analysed the effect of mutations in the C-terminal domain of nsP2, mostly in the NLS sequence, on the cytotoxicity of SFV genomes and replicons.
The present study indicated that the NLS of nsP2 is crucial and multifunctional. Changes of single amino acid residues in the region were tolerated, but deletions of one or two arginine residues or changes of two arginine residues always resulted in a temperature-sensitive phenotype. Three changes drastically reduced infectivity, but the mutant replicon was still able to replicate in a few transfected cells. Deletion of all three arginines was lethal and no replication occurred. The nature of these defects was not analysed in detail, but were most likely defects in the viral replicase complex formation and/or functioning. As temperature-sensitive mutations in nsP2 of SFV have defects in protease function (Balistreri et al., 2007), it is possible that the protease activity of nsP2 may be one function affected by NLS mutations.
Similar to previous studies (Rikkonen, 1996; Rikkonen et al., 1992, 1994b), it was found that the RRD mutation in the NLS did not prevent nsP2 transport to the nucleus, whereas localization of nsP2 with an RDR, DDR, R or RDD mutation was mostly or exclusively cytoplasmic. However, deletion of one arginine residue in the NLS resulted in enhanced nuclear transport of the nsP2, similar to SFV4-PG-infected cells. Previous studies (Rikkonen, 1996) have shown that nsP2 expressed by SFV4-RDR is exclusively cytoplasmic. In contrast, some nuclear localization was detected in this study (Fig. 1a, b). It is possible that a delay in non-structural polyprotein processing, observed for SFV4-RDR at 37 °C (Rikkonen, 1996) but not at 28 °C (Fig. 2), contributed to that difference.
There was no strict correlation between nuclear localization of nsP2 and cytotoxicity. The nsP2 proteins encoded by mutant replicons with cytotoxicity retained some nuclear localization (Figs 1 and 3); however, one of the least cytotoxic mutants, SFV4-PG (Figs 3–5), had enhanced transport of nsP2 into the nucleus (Fig. 1). The differences in cytotoxicity of SFV replicons cannot be explained by the levels of nsP2 expression, as all replicons expressed non-structural proteins at very similar levels (Fig. 6d, data not shown for nsP2–4).
Synthesis of viral RNA is one factor that may contribute to virus-induced cytotoxicity. Accordingly, synthesis of positive-strand RNAs in cells co-transfected with different replicons and H-SG-EnhLuc RNA was analysed. For SFV1-MCS-RDD and SFV-MCS-PG, the accumulation of replicon RNA was severely reduced (Fig. 7b), indicating that the RDD and PG mutations affected transcription from the genomic promoter. A similar reduction in genomic RNA synthesis has been reported for persistently replicating SFV and SIN replicons with different mutations in nsP2 (Sawicki et al., 2006). In the present study, sgRNA synthesis was less affected and thus the molar ratio of genomic : sgRNA was drastically changed. Again, these data are consistent with previous results on SIN and SFV replicons with mutations in the nsP2 region (Frolov et al., 1999; Perri et al., 2000).
Packaging of alphavirus-based replicon vectors relies on the ability of the viral replicase to replicate and transcribe separately provided helper RNA(s). In the present study, all mutant SFV replicons had reduced ability to replicate templates provided in trans. For SFV1-MCS-RRD and SFV1-MCS-RR replicons without obvious defects in self-replication, the ability to replicate and transcribe H-SG-EnhLuc RNA was reduced 4–6-fold; in trans activity of the replicases encoded by SFV1-MCS-PG and SFV1-MCS-RDD was below the detection limit (Fig. 7c). This finding, combined with the severely reduced replication of their replicon RNAs, may explain why SFV1-MCS-PG and SFV1-MCS-RDD were extremely inefficient in VLP production.
In part, the properties of SFV1-RDD and SFV1-PG could be due to the fact that non-cytotoxic replicons of SIN and SFV are unable to make stable replicase complexes and exhibit continuous negative-strand RNA synthesis (Sawicki et al., 2006). Consequently, the synthesis of non-structural polyprotein and, importantly, its processing into the functional early replicase complex (P123+nsP4) should also be continuous. As a result, in cells infected with replicons containing RDD or PG mutations, the high levels of free nsP2 should greatly reduce the formation of functional replicase complexes by cleaving the non-structural polyprotein between nsP2 and nsP3. This should become especially crucial for formation of functional replicase complexes on helper RNA, as relocalization of the unprocessed non-structural polyprotein would be needed. The findings that replication levels of SFV1-RDD and SFV1-PG were low and that these constructs were severely defective in replication of co-transfected helper RNAs are coherent with this hypothesis.
Another property of the SFV replicons and genomes with PG and RDD mutations was apparent inhibition of transfected cell division. This was evident from the lack of increase of host protein expression in cell cultures transfected with SFV1-d1EGFP-PG, SFV1-d1EGFP-RDD, SFV4-PG or SFV4-RDD (Figs 4 and 5). Additionally, the number of cells transfected with SFV1-Pac-RDD and SFV1-Pac-PG remained almost unchanged, even after prolonged incubation (Fig. 3), and cells transfected with SFV1-Pac-RDD and SFV1-Pac-PG formed very few colonies under puromycin selection at 28 °C (data not shown). In contrast, highly efficient colony formation has been reported for cells transfected with non-cytotoxic SIN replicons (Frolov et al., 1999; unpublished data).
Both SFV4-PG and SFV4-RDD viruses converted the phenotype from non-cytotoxic (Fig. 5a) to cytotoxic (Fig. 5b). This differed from SIN/G virus, which maintains non-cytotoxic properties (Gorchakov et al., 2005). The conversion was accompanied by increased synthesis of viral structural proteins (Fig. 5b) and was not caused by reversion of the original mutations. The conversion was possibly due to the advent, selection and accumulation of compensatory mutations. The accumulation of SFV genomes with compensatory mutations has been found in response to low initial infectivity of mutant genomes (Zusinaite et al., 2007). However, in the present study, SFV4-PG and SFV4-RDD did not have defects in infectivity; both in vitro-transcribed replicon RNAs and full-length genomic RNAs resulted in >95 % transfected cells (data not shown). Therefore, low efficiency of virion formation is the most likely defect causing accumulation of compensatory mutations. This assumption can also explain why the properties of SIN/G differ from those of SFV4-RDD and SFV4-PG. The level of RNA replication and structural protein expression of SIN/G is relatively high (Gorchakov et al., 2005) and there was no selection pressure for genotypes that formed more particles than the original mutant.
|
ACKNOWLEDGEMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Balistreri, G., Caldentey, J., Kaariainen, L. & Ahola, T. (2007). Enzymatic defects of the nsP2 proteins of Semliki Forest virus temperature-sensitive mutants. J Virol 81, 2849–2860.
Dryga, S. A., Dryga, O. A. & Schlesinger, S. (1997). Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene. Virology 228, 74–83.[CrossRef][Medline]
Fazakerley, J. K., Boyd, A., Mikkola, M. L. & Kaariainen, L. (2002). A single amino acid change in the nuclear localization sequence of the nsP2 protein affects the neurovirulence of Semliki Forest virus. J Virol 76, 392–396.
Frolov, I., Agapov, E., Hoffman, T. A., Jr, Pragai, B. M., Lippa, M., Schlesinger, S. & Rice, C. M. (1999). Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J Virol 73, 3854–3865.
Garmashova, N., Gorchakov, R., Frolova, E. & Frolov, I. (2006). Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J Virol 80, 5686–5696.
Garmashova, N., Gorchakov, R., Volkova, E., Paessler, S., Frolova, E. & Frolov, I. (2007). The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol 81, 2472–2484.
Glasgow, G. M., McGee, M. M., Sheahan, B. J. & Atkins, G. J. (1997). Death mechanisms in cultured cells infected by Semliki Forest virus. J Gen Virol 78, 1559–1563.[Abstract]
Gomez de Cedron, M., Ehsani, N., Mikkola, M. L., Garcia, J. A. & Kaariainen, L. (1999). RNA helicase activity of Semliki Forest virus replicase protein NSP2. FEBS Lett 448, 19–22.[CrossRef][Medline]
Gorchakov, R., Frolova, E., Williams, B. R., Rice, C. M. & Frolov, I. (2004). PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection. J Virol 78, 8455–8467.
Gorchakov, R., Frolova, E. & Frolov, I. (2005). Inhibition of transcription and translation in Sindbis virus-infected cells. J Virol 79, 9397–9409.
Karlsson, G. B. & Liljestrom, P. (2003). Live viral vectors: Semliki Forest virus. Methods Mol Med 87, 69–82.[Medline]
Liljestrom, P. & Garoff, H. (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology (N Y) 9, 1356–1361.[CrossRef][Medline]
Liljestrom, P., Lusa, S., Huylebroeck, D. & Garoff, H. (1991). In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol 65, 4107–4113.
Lundstrom, K., Rotmann, D., Hermann, D., Schneider, E. M. & Ehrengruber, M. U. (2001). Novel mutant Semliki Forest virus vectors: gene expression and localization studies in neuronal cells. Histochem Cell Biol 115, 83–91.[Medline]
Lundstrom, K., Abenavoli, A., Malgaroli, A. & Ehrengruber, M. U. (2003). Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression. Mol Ther 7, 202–209.[CrossRef][Medline]
Nieva, J. L., Sanz, M. A. & Carrasco, L. (2004). Membrane-permeabilizing motif in Semliki forest virus E1 glycoprotein. FEBS Lett 576, 417–422.[CrossRef][Medline]
Peranen, J., Rikkonen, M., Liljestrom, P. & Kaariainen, L. (1990). Nuclear localization of Semliki Forest virus-specific nonstructural protein nsP2. J Virol 64, 1888–1896.
Perri, S., Driver, D. A., Gardner, J. P., Sherrill, S., Belli, B. A., Dubensky, T. W., Jr & Polo, J. M. (2000). Replicon vectors derived from Sindbis virus and Semliki forest virus that establish persistent replication in host cells. J Virol 74, 9802–9807.
Rikkonen, M. (1996). Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2. Virology 218, 352–361.[CrossRef][Medline]
Rikkonen, M., Peranen, J. & Kaariainen, L. (1992). Nuclear and nucleolar targeting signals of Semliki Forest virus nonstructural protein nsP2. Virology 189, 462–473.[CrossRef][Medline]
Rikkonen, M., Peranen, J. & Kaariainen, L. (1994a). ATPase and GTPase activities associated with Semliki Forest virus nonstructural protein nsP2. J Virol 68, 5804–5810.
Rikkonen, M., Peranen, J. & Kaariainen, L. (1994b). Nuclear targeting of Semliki Forest virus nsP2. Arch Virol Suppl 9, 369–377.[Medline]
Salonen, A., Vasiljeva, L., Merits, A., Magden, J., Jokitalo, E. & Kaariainen, L. (2003). Properly folded nonstructural polyprotein directs the Semliki Forest virus replication complex to the endosomal compartment. J Virol 77, 1691–1702.
Sawicki, D. L., Perri, S., Polo, J. M. & Sawicki, S. G. (2006). Role for nsP2 proteins in the cessation of alphavirus minus-strand synthesis by host cells. J Virol 80, 360–371.
Singh, I. & Helenius, A. (1992). Role of ribosomes in Semliki Forest virus nucleocapsid uncoating. J Virol 66, 7049–7058.
Sjoberg, E. M., Suomalainen, M. & Garoff, H. (1994). A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene. Biotechnology (N Y) 12, 1127–1131.[CrossRef][Medline]
Smerdou, C. & Liljestrom, P. (1999). Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol 73, 1092–1098.
Strauss, J. H. & Strauss, E. G. (1994). The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58, 491–562.
Vasiljeva, L., Merits, A., Auvinen, P. & Kaariainen, L. (2000). Identification of a novel function of the alphavirus capping apparatus. RNA 5'-triphosphatase activity of Nsp2. J Biol Chem 275, 17281–17287.
Wengler, G., Koschinski, A., Wengler, G. & Dreyer, F. (2003). Entry of alphaviruses at the plasma membrane converts the viral surface proteins into an ion-permeable pore that can be detected by electrophysiological analyses of whole-cell membrane currents. J Gen Virol 84, 173–181.
White, C. L., Thomson, M. & Dimmock, N. J. (1998). Deletion analysis of a defective interfering Semliki Forest virus RNA genome defines a region in the nsP2 sequence that is required for efficient packaging of the genome into virus particles. J Virol 72, 4320–4326.
Zusinaite, E., Tints, K., Kiiver, K., Spuul, P., Karo-Astover, L., Merits, A. & Sarand, I. (2007). Mutations at the palmitoylation site of non-structural protein nsP1 of Semliki Forest virus attenuate virus replication and cause accumulation of compensatory mutations. J Gen Virol 88, 1977–1985.
Received 14 July 2007;
accepted 22 November 2007.
This article has been cited by other articles:
|
|
 |
|
  K. Kiiver, I. Tagen, E. Zusinaite, N. Tamberg, J. K. Fazakerley, and A. Merits Properties of non-structural protein 1 of Semliki Forest virus and its interference with virus replication J. Gen. Virol., June 1, 2008; 89(6): 1457 - 1466. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
